The global Prostate-specific Antigen (PSA) Testing market is projected to grow from US$ 528.3 million in 2024 to US$ 628.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.9% during the forecast period.

Prostate-specific Antigen (PSA) Testing Market

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK4 gene.

The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la୐

Market Analysis and Insights: Global Prostate-specific Antigen (PSA) Testing Market

The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 81% of the global market. CLIA is th୅

Report Covers:

This report presents an overview of global market for Prostate-specific Antigen (PSA) Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Prostate-specific Antigen (PSA) Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate-specific Antigen (PSA) Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostate-specific Antigen (PSA) Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate-specific Antigen (PSA) Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate-specific Antigen (PSA) Testing revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Prostate-specific Antigen (PSA) Testing Market Report

Report Metric	Details
Report Name	Prostate-specific Antigen (PSA) Testing Market
Accounted market size in 2024	US$ 528.3 million
Forecasted market size in 2030	US$ 628.6 million
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	CLIA Method ELISA Method
Segment by Application	Screening Post-treatment Monitoring Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Boston Scientific Corporation, Bayer AG, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch, BodiTech, Bristol-Myers Squibb Company, GE Healthcare, Endocare, Merck＆Co., Medtronic, Sanofi-Aventis SA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostate-specific Antigen (PSA) Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate-specific Antigen (PSA) Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate-specific Antigen (PSA) Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

What is the Prostate-specific Antigen (PSA) Testing Market size in 2030?

Ans: The Prostate-specific Antigen (PSA) Testing Market size in 2030 will be US$ 628.6 million.

What is the market share of major companies in Prostate-specific Antigen (PSA) Testing Market?

Ans: The top 3 players occupy about 50% shares of the global market.

Who are the main players in the Prostate-specific Antigen (PSA) Testing Market report?

Ans: The main players in the Prostate-specific Antigen (PSA) Testing Market are Abbott, Boston Scientific Corporation, Bayer AG, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch, BodiTech, Bristol-Myers Squibb Company, GE Healthcare, Endocare, Merck＆Co., Medtronic, Sanofi-Aventis SA

What are the Application segmentation covered in the Prostate-specific Antigen (PSA) Testing Market report?

Ans: The Applications covered in the Prostate-specific Antigen (PSA) Testing Market report are Screening, Post-treatment Monitoring, Other

What are the Type segmentation covered in the Prostate-specific Antigen (PSA) Testing Market report?

Ans: The Types covered in the Prostate-specific Antigen (PSA) Testing Market report are CLIA Method, ELISA Method

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 CLIA Method

1.2.3 ELISA Method

1.3 Market by Application

1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Screening

1.3.3 Post-treatment Monitoring

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate-specific Antigen (PSA) Testing Market Perspective (2019-2030)

2.2 Global Prostate-specific Antigen (PSA) Testing Growth Trends by Region

2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Size by Region (2019-2024)

2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2025-2030)

2.3 Prostate-specific Antigen (PSA) Testing Market Dynamics

2.3.1 Prostate-specific Antigen (PSA) Testing Industry Trends

2.3.2 Prostate-specific Antigen (PSA) Testing Market Drivers

2.3.3 Prostate-specific Antigen (PSA) Testing Market Challenges

2.3.4 Prostate-specific Antigen (PSA) Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Prostate-specific Antigen (PSA) Testing by Players

3.1.1 Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2019-2024)

3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2019-2024)

3.2 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Prostate-specific Antigen (PSA) Testing, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio

3.4.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2023

3.5 Global Key Players of Prostate-specific Antigen (PSA) Testing Head office and Area Served

3.6 Global Key Players of Prostate-specific Antigen (PSA) Testing, Product and Application

3.7 Global Key Players of Prostate-specific Antigen (PSA) Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate-specific Antigen (PSA) Testing Breakdown Data by Type

4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2019-2024)

4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2025-2030)

5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application

5.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2019-2024)

5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)

6.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type

6.2.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)

6.2.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)

6.2.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Application

6.3.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)

6.3.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)

6.3.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Country

6.4.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)

6.4.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)

7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type

7.2.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)

7.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)

7.2.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application

7.3.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)

7.3.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)

7.3.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country

7.4.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)

7.4.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)

8.2 China Prostate-specific Antigen (PSA) Testing Market Size by Type

8.2.1 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)

8.2.2 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)

8.2.3 China Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

8.3 China Prostate-specific Antigen (PSA) Testing Market Size by Application

8.3.1 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)

8.3.2 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)

8.3.3 China Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)

9.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Type

9.2.1 Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)

9.2.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)

9.2.3 Asia Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

9.3 Asia Prostate-specific Antigen (PSA) Testing Market Size by Application

9.3.1 Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)

9.3.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)

9.3.3 Asia Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

9.4 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region

9.4.1 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024)

9.4.3 Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type

10.2.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application

10.3.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country

10.4.1 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction

11.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.1.5 Abbott Recent Developments

11.2 Boston Scientific Corporation

11.2.1 Boston Scientific Corporation Company Details

11.2.2 Boston Scientific Corporation Business Overview

11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction

11.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.2.5 Boston Scientific Corporation Recent Developments

11.3 Bayer AG

11.3.1 Bayer AG Company Details

11.3.2 Bayer AG Business Overview

11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction

11.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.3.5 Bayer AG Recent Developments

11.4 Siemens Healthcare

11.4.1 Siemens Healthcare Company Details

11.4.2 Siemens Healthcare Business Overview

11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction

11.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.4.5 Siemens Healthcare Recent Developments

11.5 DiaSorin

11.5.1 DiaSorin Company Details

11.5.2 DiaSorin Business Overview

11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction

11.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.5.5 DiaSorin Recent Developments

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction

11.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.6.5 Roche Recent Developments

11.7 Beckman Coulter

11.7.1 Beckman Coulter Company Details

11.7.2 Beckman Coulter Business Overview

11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction

11.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.7.5 Beckman Coulter Recent Developments

11.8 PerkinElmer

11.8.1 PerkinElmer Company Details

11.8.2 PerkinElmer Business Overview

11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction

11.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.8.5 PerkinElmer Recent Developments

11.9 Tosoh

11.9.1 Tosoh Company Details

11.9.2 Tosoh Business Overview

11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction

11.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.9.5 Tosoh Recent Developments

11.10 Ortho Clinical

11.10.1 Ortho Clinical Company Details

11.10.2 Ortho Clinical Business Overview

11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction

11.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.10.5 Ortho Clinical Recent Developments

11.11 Fujirebio

11.11.1 Fujirebio Company Details

11.11.2 Fujirebio Business Overview

11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction

11.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.11.5 Fujirebio Recent Developments

11.12 Mediwatch

11.12.1 Mediwatch Company Details

11.12.2 Mediwatch Business Overview

11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction

11.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.12.5 Mediwatch Recent Developments

11.13 BodiTech

11.13.1 BodiTech Company Details

11.13.2 BodiTech Business Overview

11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction

11.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.13.5 BodiTech Recent Developments

11.14 Bristol-Myers Squibb Company

11.14.1 Bristol-Myers Squibb Company Company Details

11.14.2 Bristol-Myers Squibb Company Business Overview

11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction

11.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.14.5 Bristol-Myers Squibb Company Recent Developments

11.15 GE Healthcare

11.15.1 GE Healthcare Company Details

11.15.2 GE Healthcare Business Overview

11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction

11.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.15.5 GE Healthcare Recent Developments

11.16 Endocare

11.16.1 Endocare Company Details

11.16.2 Endocare Business Overview

11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction

11.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.16.5 Endocare Recent Developments

11.17 Merck＆Co.

11.17.1 Merck＆Co. Company Details

11.17.2 Merck＆Co. Business Overview

11.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Introduction

11.17.4 Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.17.5 Merck＆Co. Recent Developments

11.18 Medtronic

11.18.1 Medtronic Company Details

11.18.2 Medtronic Business Overview

11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction

11.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.18.5 Medtronic Recent Developments

11.19 Sanofi-Aventis SA

11.19.1 Sanofi-Aventis SA Company Details

11.19.2 Sanofi-Aventis SA Business Overview

11.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction

11.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

11.19.5 Sanofi-Aventis SA Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Boston Scientific Corporation

Bristol Myers Squibb Company

Medtronic Inc

Sanofi-Aventis SA

List of Tables

Table 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of CLIA Method

Table 3. Key Players of ELISA Method

Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2019-2024)

Table 8. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2025-2030)

Table 10. Prostate-specific Antigen (PSA) Testing Market Trends

Table 11. Prostate-specific Antigen (PSA) Testing Market Drivers

Table 12. Prostate-specific Antigen (PSA) Testing Market Challenges

Table 13. Prostate-specific Antigen (PSA) Testing Market Restraints

Table 14. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players (2019-2024)

Table 16. Global Top Prostate-specific Antigen (PSA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2023)

Table 17. Global Prostate-specific Antigen (PSA) Testing Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Prostate-specific Antigen (PSA) Testing, Headquarters and Area Served

Table 20. Global Key Players of Prostate-specific Antigen (PSA) Testing, Product and Application

Table 21. Global Key Players of Prostate-specific Antigen (PSA) Testing, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2019-2024)

Table 25. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2025-2030)

Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2019-2024)

Table 29. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2025-2030)

Table 31. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Prostate-specific Antigen (PSA) Testing Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030) & (US$ Million)

Table 63. Abbott Company Details

Table 64. Abbott Business Overview

Table 65. Abbott Prostate-specific Antigen (PSA) Testing Product

Table 66. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 67. Abbott Recent Developments

Table 68. Boston Scientific Corporation Company Details

Table 69. Boston Scientific Corporation Business Overview

Table 70. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product

Table 71. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 72. Boston Scientific Corporation Recent Developments

Table 73. Bayer AG Company Details

Table 74. Bayer AG Business Overview

Table 75. Bayer AG Prostate-specific Antigen (PSA) Testing Product

Table 76. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 77. Bayer AG Recent Developments

Table 78. Siemens Healthcare Company Details

Table 79. Siemens Healthcare Business Overview

Table 80. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product

Table 81. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 82. Siemens Healthcare Recent Developments

Table 83. DiaSorin Company Details

Table 84. DiaSorin Business Overview

Table 85. DiaSorin Prostate-specific Antigen (PSA) Testing Product

Table 86. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 87. DiaSorin Recent Developments

Table 88. Roche Company Details

Table 89. Roche Business Overview

Table 90. Roche Prostate-specific Antigen (PSA) Testing Product

Table 91. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 92. Roche Recent Developments

Table 93. Beckman Coulter Company Details

Table 94. Beckman Coulter Business Overview

Table 95. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product

Table 96. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 97. Beckman Coulter Recent Developments

Table 98. PerkinElmer Company Details

Table 99. PerkinElmer Business Overview

Table 100. PerkinElmer Prostate-specific Antigen (PSA) Testing Product

Table 101. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 102. PerkinElmer Recent Developments

Table 103. Tosoh Company Details

Table 104. Tosoh Business Overview

Table 105. Tosoh Prostate-specific Antigen (PSA) Testing Product

Table 106. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 107. Tosoh Recent Developments

Table 108. Ortho Clinical Company Details

Table 109. Ortho Clinical Business Overview

Table 110. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product

Table 111. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 112. Ortho Clinical Recent Developments

Table 113. Fujirebio Company Details

Table 114. Fujirebio Business Overview

Table 115. Fujirebio Prostate-specific Antigen (PSA) Testing Product

Table 116. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 117. Fujirebio Recent Developments

Table 118. Mediwatch Company Details

Table 119. Mediwatch Business Overview

Table 120. Mediwatch Prostate-specific Antigen (PSA) Testing Product

Table 121. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 122. Mediwatch Recent Developments

Table 123. BodiTech Company Details

Table 124. BodiTech Business Overview

Table 125. BodiTech Prostate-specific Antigen (PSA) Testing Product

Table 126. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 127. BodiTech Recent Developments

Table 128. Bristol-Myers Squibb Company Company Details

Table 129. Bristol-Myers Squibb Company Business Overview

Table 130. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product

Table 131. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 132. Bristol-Myers Squibb Company Recent Developments

Table 133. GE Healthcare Company Details

Table 134. GE Healthcare Business Overview

Table 135. GE Healthcare Prostate-specific Antigen (PSA) Testing Product

Table 136. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 137. GE Healthcare Recent Developments

Table 138. Endocare Company Details

Table 139. Endocare Business Overview

Table 140. Endocare Prostate-specific Antigen (PSA) Testing Product

Table 141. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 142. Endocare Recent Developments

Table 143. Merck＆Co. Company Details

Table 144. Merck＆Co. Business Overview

Table 145. Merck＆Co. Prostate-specific Antigen (PSA) Testing Product

Table 146. Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 147. Merck＆Co. Recent Developments

Table 148. Medtronic Company Details

Table 149. Medtronic Business Overview

Table 150. Medtronic Prostate-specific Antigen (PSA) Testing Product

Table 151. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 152. Medtronic Recent Developments

Table 153. Sanofi-Aventis SA Company Details

Table 154. Sanofi-Aventis SA Business Overview

Table 155. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product

Table 156. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024) & (US$ Million)

Table 157. Sanofi-Aventis SA Recent Developments

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2023 VS 2030

Figure 3. CLIA Method Features

Figure 4. ELISA Method Features

Figure 5. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2023 VS 2030

Figure 7. Screening Case Studies

Figure 8. Post-treatment Monitoring Case Studies

Figure 9. Other Case Studies

Figure 10. Prostate-specific Antigen (PSA) Testing Report Years Considered

Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Prostate-specific Antigen (PSA) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Prostate-specific Antigen (PSA) Testing Market Share by Region: 2023 VS 2030

Figure 14. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2023

Figure 15. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2023

Figure 17. North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

Figure 19. North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

Figure 20. North America Prostate-specific Antigen (PSA) Testing Market Share by Country (2019-2030)

Figure 21. United States Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

Figure 25. Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

Figure 26. Europe Prostate-specific Antigen (PSA) Testing Market Share by Country (2019-2030)

Figure 27. Germany Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

Figure 35. China Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

Figure 36. Asia Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

Figure 38. Asia Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

Figure 39. Asia Prostate-specific Antigen (PSA) Testing Market Share by Region (2019-2030)

Figure 40. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Prostate-specific Antigen (PSA) Testing Market Share by Country (2019-2030)

Figure 50. Brazil Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 57. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 58. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 59. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 60. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 61. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 62. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 63. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 64. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 65. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 66. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 67. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 68. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 69. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 70. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 71. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 72. Merck＆Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 73. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 74. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2019-2024)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions